why choose us

First received: August 1, 2022

Clinical Trial: A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Polycythemia Vera

Study Type: Interventional


Official Title: A Phase II Single-Arm Multicenter Study to Access Efficacy and Safety of P1101 in Chinese Polycythemia Vera Patients Who Are Intolerant or Resistance to Hydroxyurea

Brief Summary: This study is a phase II single-arm study designed to evaluate the efficacy and safety of P1101 in Chinese PV patients who are intolerance or resistance to HU.

Read more